In conclusion, we determined that postoperative adjuvant treatment with TOC was associated with a significantly longer TTP for dogs with adenocarcinomas compared to treatment by surgery alone, and that this inhibition of recurrence possibly is caused by the long‐term inhibition of Tregs, VEGFR2, and HIF‐1α associated with TOC treatment. This evidence concerns the gene HIF1A and adenocarcinoma.